J&J Rides Standalone Consumer Health Track

J&J takes same approach GSK, Pfizer, Merck & Co, Merck and Novartis have with their consumer health businesses, Bausch Health is starting and Sanofi says it will.

• Source: Alamy

At this rate, before long the drug industry may not include any major firms that manufacture products marketed on both sides of the Rx and OTC divide.

With its announcement on 12 November to separate its consumer health business as a standalone, publicly traded company within two years, Johnson & Johnson is taking the same approach that GlaxoSmithKline plcPfizer Inc.Merck & Co., Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

Coty’s Next Phase Of ‘All-In To Win’ Strategy Should Generate $130M Savings

 

Coty’s ‘All-in to Win’ program enters the next phase, which sets aggressive savings over the next two years in part by simplifying and scaling its operating model, in addition to boosting its innovation impact.

Cosmetic Industry Deals: ELC/Biotech Partnership Will Further Lauder’s Skin Longevity Push; L’Oréal Cuts Ribbon On $160M US Innovation Center

 

Estee Lauder Companies collaborates with Serpin Pharma to explore anti-inflammatory innovation and skin longevity, while L’Oréal Group celebrates the grand opening of North America Research & Innovation Center with ribbon cutting event.

Unilever CEO’s Sudden Departure Has Investment Community Speculating

 

British consumer goods firm Unilever PLC announces it will replace CEO Hein Schumacher with CFO and Executive Director Fernando Fernandez 1 March.

Coty Establishes ‘Competitive Moat’ For Prestige Fragrance Against Upstarts, ‘Dupes’ – CEO

 

Coty Inc.’s ‘competitive moat’ against upstarts and ‘dupe” competition is a five-step strategy that includes investing in master perfumers over external suppliers and the use of ‘rare, exclusive’ ingredients in scents.

More from Business

P&G: Innovation, Pricing ‘Short-Term Levers’ For Tariffs Adding Up To $1.5Bn In Costs Annually

 

The Procter & Gamble Company is working to mitigate the impact of tariffs, which will add up to $1.5bn in costs annually. The firm has lowered its fiscal 2025 outlook.

NAD Refers Men’s Hair Color Brand To FTC For Non-Compliance With Fast-Track SWIFT Decision

 

Plano, Texas-based Simpler Hair Color Inc. may face FTC enforcement action after it failed to comply with the National Advertising Division’s recommendations it discontinue the claim, “Rated #1 Men’s Hair Color,” associated with a consumer review website.

Beiersdorf Repositioning In China Will Get Boost From Thiamidol Launch

 

Beiersdorf AG hit some initial bumps with a repositioning of its business in China, but the firm is optimistic about the rollout of Thiamidol Skin Care In 2026.